John Stegmayr
11 – 20 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Targeting Alveolar Repair in Idiopathic Pulmonary Fibrosis
(
- Contribution to journal › Article
- 2020
-
Mark
Lung regeneration : implications of the diseased niche and ageing
(
- Contribution to journal › Article
-
Mark
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Extracellular and intracellular small-molecule galectin-3 inhibitors
(
- Contribution to journal › Article
-
Mark
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
(
- Contribution to journal › Article
- 2018
-
Mark
Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin–glycan specificities in a natural context
(
- Contribution to journal › Article
-
Mark
The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin
(
- Contribution to journal › Article
- 2017
-
Mark
Galectin Inhibitors – Molecular Tools in Biomedical Research and Clinical Implications
2017)(
- Thesis › Doctoral thesis (compilation)
- 2016
-
Mark
Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition
(
- Contribution to journal › Article
-
Mark
Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans
(
- Contribution to journal › Article